In vitro activity of HR 810, a new cephalosporin
- 1 August 1984
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (2) , 277-279
- https://doi.org/10.1128/aac.26.2.277
Abstract
The in vitro susceptibility of 409 clinical isolates to HR 810, a new cephalosporin, was evaluated and compared with their susceptibility to aztreonam, cefazolin, ceftazidime, imipenem, moxalactam, piperacillin, and gentamicin. On a weight basis, the activity of HR 810 against gram-negative bacilli was equivalent or superior to that of the other beta-lactam agents except imipenem.Keywords
This publication has 11 references indexed in Scilit:
- Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810European Journal of Clinical Microbiology & Infectious Diseases, 1983
- Relation between beta-lactamase production and antimicrobial activity: Comparison of the new compound HR 810 with cefotaximeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum.1983
- Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infectionsAntimicrobial Agents and Chemotherapy, 1982
- Coagulopathy Associated With the Use of MoxalactamJAMA, 1982
- The New Beta-Lactamase-Stable CephalosporinsAnnals of Internal Medicine, 1982
- A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivativesAntimicrobial Agents and Chemotherapy, 1982
- Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adultsAntimicrobial Agents and Chemotherapy, 1982
- Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapyAntimicrobial Agents and Chemotherapy, 1981
- Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1980